Anika Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	199	133	237	332	433	517
Market Cap Growth	-3.21%	-43.75%	-28.57%	-23.26%	-16.34%	-20.22%
Enterprise Value	188.96	100.19	205.67	289.37	375.39	442.28
Last Close Price	14.99	9.61	16.46	22.66	29.60	35.83
PE Ratio	-	-13.73	-27.43	-98.52	197.33	127.96
Forward PE	66.70	53.39	39.19	-	-	-
PEG Ratio	6.43	4.60	4.60	-	-	161.40
PS Ratio	1.76	1.18	1.98	2.75	3.80	3.50
PB Ratio	1.48	0.93	1.54	1.57	1.52	1.80
P/TBV Ratio	1.60	0.96	1.57	1.57	1.53	1.83
P/FCF Ratio	196.57	30.60	-101.80	-46.04	-140.69	159.01
P/OCF Ratio	31.56	11.93	43.92	-185.79	98.19	61.62
EV/Sales Ratio	1.63	0.89	1.72	2.40	3.30	2.99
EV/EBITDA Ratio	-	-18.83	68.10	19.21	20.67	18.90
EV/EBIT Ratio	-	-9.07	-40.32	342.86	102.29	169.13
EV/FCF Ratio	181.86	22.97	-88.23	-40.11	-122.00	135.92
Debt / Equity Ratio	0.18	0.17	0.16	0.12	0.10	0.07
Debt / EBITDA Ratio	-3.55	-4.55	7.95	1.72	1.59	0.82
Debt / FCF Ratio	22.90	5.55	-10.30	-3.59	-9.36	5.91
Net Debt / Equity Ratio	-0.13	-0.23	-0.20	-0.20	-0.20	-0.26
Net Debt / EBITDA Ratio	2.57	6.25	-10.47	-2.84	-3.17	-3.21
Net Debt / FCF Ratio	-16.58	-7.63	13.56	5.94	18.69	-23.09
Asset Turnover	0.63	0.57	0.51	0.39	0.33	0.41
Inventory Turnover	2.31	2.30	1.82	1.19	1.07	1.58
Quick Ratio	3.19	3.71	3.40	3.06	4.33	4.17
Current Ratio	4.46	4.72	4.88	5.26	6.07	5.66
Return on Equity (ROE)	-7.99%	-6.71%	-4.82%	-1.38%	0.77%	1.48%
Return on Assets (ROA)	-7.16%	-6.03%	-6.88%	-0.30%	0.54%	1.25%
Return on Invested Capital (ROIC)	-11.59%	-9.92%	-10.53%	-0.44%	0.81%	1.89%
Return on Capital Employed (ROCE)	-7.50%	-6.35%	-2.43%	0.30%	1.15%	0.81%
Earnings Yield	-5.42%	-7.28%	-3.65%	-1.01%	0.51%	0.78%
FCF Yield	0.51%	3.27%	-0.98%	-2.17%	-0.71%	0.63%
Buyback Yield / Dilution	3.24%	2.59%	-0.44%	0.89%	-1.05%	-2.90%
Total Shareholder Return	3.24%	2.59%	-0.44%	0.89%	-1.05%	-2.90%

Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q